All In MedTech

Device Trial Radar · NCT02260856

A Randomized Controlled Trial of Leg Length Discrepancy Techniques

PEDS Trial: Percutaneous Epiphysiodesis, Drill Versus Screws for Leg Length Discrepancy a Randomized Clinical Trial

Last checked: Nov 19, 2026Latest source record: Jan 24, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedPivotal-lookingRandomized with 170 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

170

Planned (sponsor's estimate)

Start

Jun 2015

Primary completion

Dec 2023

Study completion Dec 2023

Sponsor

Lead sponsor
Hospital for Special Surgery, New YorkAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Boston Children's Hospital; The Hospital for Sick Children
First posted
Oct 9, 2014

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 7 years, up to 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a randomized clinical trial of epiphysiodesis techniques: percutaneous transphyseal screw epiphysiodesis versus percutaneous drill epiphysiodesis for the correction of leg length discrepancy. Failed epiphysiodesis was selected as the primary outcome. Failed epiphysiodesis was defined as one or more of the following: development of angular deformity \> 5°, revision epiphysiodesis, or growth inhibition \< 70% of expected. EOS, low dose biplanar X-Ray, will be used to make all length measurements. Secondary outcomes assess mean growth at the physis following epiphysiodesis, in the subset of patients with bead implantation, fluoroscopy and operative times, length of stay, return to full weight bearing, as well as functional and quality of life outcomes. The following outcome scales will be used to measure pain (VAS), quality of life (PROMIS Pediatric Pain Interference Scale), and function (PROMIS Pediatric Mobility Scale, Pedi-FABS, and UCLA Activity Score). Each of these scales has been validated for use in children (Beyer, Denyes, \& Villarruel, 1992; DeWitt et al., 2011; Fabricant et al., 2013; Novais et al., 2014; Varni et al., 2010a). We will also determine the cost associated with each technique and perform a cost-effectiveness analysis to establish which technique is preferred from a societal perspective.

Conditions

  • Leg Length Discrepancy

Interventions

  • Tantalum Beads & InjectorDevice

    To measure growth at physis, four tantalum beads will be implanted per physis at baseline and take radiostereometric analysis measurements at all follow up timepoints. Tantalum beads have been used to make detailed three dimensional radiographic measurements in orthopedic and other specialties

  • Percutaneous Drill EpiphysiodesisProcedure

  • Percutaneous Screw EpiphysiodesisProcedure

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Failure of EpiphysiodesisTime frame: 2-6 weeks, 5-7 months, 11-13 months, 23-25 months, 59-61 months

Locations

3 sites in 2 countries. Site status is shown where the registry gives one.

  • Boston Children's Hospital

    Boston, Massachusetts

  • Hospital for Special Surgery

    New York, New York

  • Hospital for Sick Children

    Toronto, Ontario, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.